Nasdaq:US$38.93 (+1.39) | HKEX:HK$60.10 (+0.40) | AIM:£5.56 (+0.14)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 29 Jul 2009

Patient Enrolment Completed Ahead of Schedule for the Global Phase IIb Ulcerative Colitis Trial of HMPL-004

1 items
a090729